ALLO icon

Allogene Therapeutics
ALLO

Overview Fund Trends Analyst Outlook Journalist POV

79 hedge funds and large institutions have $1.67B invested in Allogene Therapeutics in 2018 Q4 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership: →

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$912K
Puts
$16K
Net Calls
Net Calls Change

Top Buyers

1
+$623M
2
+$130M
3
+$65.9M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$62.6M
5
Capital World Investors
Capital World Investors
California
+$58.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$623M
2
$207M
3
$130M
4
$65.9M
5
$62.6M
6
$58.5M
7
$56M
8
$55.1M
9
$54.7M
10
$41.6M
11
$34.6M
12
$27.8M
13
$27.4M
14
$22.2M
15
$17.5M
16
$16.6M
17
$13.4M
18
$10.8M
19
$10.8M
20
$10.8M
21
$9.98M
22
$9.59M
23
$9.55M
24
$8.8M
25
$8.59M
1
2 3 4